Biocon acquires business assets of Acacia Lifesciences

03 Oct 2015 Evaluate

Biocon has acquired the business assets of the pharmaceutical manufacturing unit of Acacia Lifesciences located at Vishakapatnam with effect from October 01, 2015 on a going concern basis. This unit is presently manufacturing advanced intermediates of potent APIs useful to the company’s business as well as for supply to third party customers.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Biocon Share Price

391.75 1.50 (0.38%)
30-Dec-2025 14:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.70
Dr. Reddys Lab 1267.20
Cipla 1486.15
Zydus Lifesciences 902.00
Lupin 2086.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×